ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998

The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.

October 19, 2001

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001